IGFBP5 Antikörper (AA 27-248)
-
- Target Alle IGFBP5 Antikörper anzeigen
- IGFBP5 (Insulin-Like Growth Factor Binding Protein 5 (IGFBP5))
-
Bindungsspezifität
- AA 27-248
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IGFBP5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Verwendungszweck
- Monoclonal Antibody to Insulin Like Growth Factor Binding Protein 5 (IGFBP5)
- Spezifität
- The antibody is a mouse monoclonal antibody raised against IGFBP5. It has been selected for its ability to recognize IGFBP5 in immunohistochemical staining and western blotting.
- Kreuzreaktivität
- Maus, Ratte
- Aufreinigung
- Protein A + Protein G affinity chromatography
- Immunogen
- Recombinant Insulin Like Growth Factor Binding Protein 5 (IGFBP5) corresdonding to Cys27~Gly248 (Accession # P24593)
- Klon
- D4
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product IGFBP5 Primärantikörper
-
-
- Applikationshinweise
-
Western blotting: 0.5-2 μg/mL
1:500-2000 Immunohistochemistry: 5-20 μg/mL
1:50-200 Immunocytochemistry: 5-20 μg/mL
1:50-200 Optimal working dilutions must be determined by end user.
- Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 24 months
-
- Target
- IGFBP5 (Insulin-Like Growth Factor Binding Protein 5 (IGFBP5))
- Andere Bezeichnung
- Insulin Like Growth Factor Binding Protein 5 (IGFBP5 Produkte)
- Synonyme
- IBP5 antikoerper, AI256729 antikoerper, AW208790 antikoerper, IGFBP-5 antikoerper, IGFBP-5P antikoerper, IGF-BP5 antikoerper, igfbp5 antikoerper, ibp5 antikoerper, IBP-5 antikoerper, xIGFBP-5 antikoerper, IGFBP5 antikoerper, igfbp5b antikoerper, zgc:165472 antikoerper, insulin like growth factor binding protein 5 antikoerper, insulin-like growth factor binding protein 5 antikoerper, insulin like growth factor binding protein 5 L homeolog antikoerper, insulin-like growth factor binding protein 5b antikoerper, insulin-like growth factor-binding protein 5 antikoerper, insulin-like growth factor binding protein 5a antikoerper, IGFBP5 antikoerper, Igfbp5 antikoerper, igfbp5.L antikoerper, igfbp5b antikoerper, igfbp5 antikoerper, LOC100194500 antikoerper, igfbp5a antikoerper
- Hintergrund
- IBP5
- Pathways
- WNT Signalweg, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process, Autophagie, Smooth Muscle Cell Migration, Growth Factor Binding
-